From June 9, 2022 to June 22, 2023, the company has repurchased 634,881 shares, representing 0.4% for AUD 1.28 million. With this, the company has completed the repurchase of 634,881 shares, representing 0.4% for AUD 1.28 million under the buyback announced on June 9, 2022.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.69 AUD | +9.03% | +38.52% | +101.19% |
03-26 | Race Oncology Obtains Certificate of Analysis for RC220; Shares Up Almost 6% | MT |
03-18 | Race Oncology Limited(ASX:RAC) dropped from S&P/ASX All Ordinaries Index | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+101.19% | 155M | |
+5.66% | 109B | |
+11.23% | 105B | |
-0.38% | 22.25B | |
-12.15% | 22.09B | |
-7.66% | 18.68B | |
-36.52% | 17.58B | |
-10.09% | 16.85B | |
+3.33% | 13.76B | |
+36.58% | 12.46B |
- Stock Market
- Equities
- RAC Stock
- News Race Oncology Limited
- Tranche Update on Race Oncology Limited's Equity Buyback Plan announced on June 9, 2022.